Reducing Cardiovascular Risk With Effective Management Of LDL Cholesterol - A Round Table Discussion

Published: 18 December 2020

  • Views:

    Views Icon 79

  • Likes:

    Heart Icon 7
  • episode_image
    2m 29s
    Part 6 Chapter 6: Summary
    Kausik (Kosh) Ray, Lale Tokgözoğlu, Christie Ballantyne
Average (ratings)
No ratings
Your rating

Overview

This round table is designed to provide clinicians with a better understanding of the long-term CV risks of LDL-C exposure. In addition to reviewing the pathogenesis of atherosclerosis and assessing the long term implications of elevated LDL-C, this meeting will consider current guidance around controlling LDL-C, the challenges in achieving LDL-C targets, and evaluate how emerging strategies are contributing to LDL-C management.

 

Each chapter will comprise of a short presentation by the named medical expert followed by a panel discussion amongst all faculty.

This medical experts round table discussion was organised independently by Radcliffe Cardiology, work that was funded by Novartis. It is intended for healthcare professionals as medical educational material, and may include data/information on investigational uses of compounds/drugs that have not yet been approved by regulatory authorities.

Learning objectives

  • Outline the pathogenic nature and clinical risk of extended exposure to elevated LDL-C
  • Describe the clinical challenges in achieving guideline-based LDL-C goals
  • Compare and contrast LDL-C lowering therapies

More from this programme

Part 1

Chapter 1: Welcome and introductions

1 session
Chapter 1: Welcome and introductions Watch now

Part 2

Chapter 2: The role of long-term exposure to elevated LDL-C in the pathogenesis of atherosclerosis and clinical risk

1 session
Chapter 2: The role of long-term exposure to elevated LDL-C in the pathogenesis of atherosclerosis and clinical risk Watch now

Part 3

Chapter 3: Current approaches to controlling LDL-C – what do the guidelines say?

1 session
Chapter 3: Current approaches to controlling LDL-C – what do the guidelines say? Watch now

Part 4

Chapter 4: Challenges in achieving guideline-based LDL-C targets in the real world

1 session
Chapter 4: Challenges in achieving guideline-based LDL-C targets in the real world Watch now

Part 5

Chapter 5: Contemporary approaches to managing LDL-C and cardiovascular risk

1 session
Chapter 5: Contemporary approaches to managing LDL-C and cardiovascular risk Watch now

Part 6

Chapter 6: Summary

1 session
Chapter 6: Summary Watch now

Faculty Biographies

Christie Ballantyne

Christie Ballantyne

Chief of Cardiology and Chief of Cardiovascular Research at Baylor College of Medicine, Houston, Texas

Christie Ballantyne is an internationally-renowned expert on lipids, atherosclerosis and heart disease prevention. His research interest in the prevention of heart disease has led him to become an established investigator for the American Heart Association and to receive continuous funding from the NIH since joining the faculty in 1988 in basic research of leukocyte- endothelial interactions, translational research in biomarkers and clinical trials.
Over the past 32 years, his many accomplishments have included being elected as Fellow of the American Association for the Advancement of Science, the American Society of Clinical Investigation, and the Association of American Physicians. In 2012 he received the American College of Cardiology Distinguished Scientist Award (Basic Domain). In 2014 and 2015, Thomson Reuters recognized Christie as one of “The World's Most Influential Scientific Minds.” Clarivate Analytics, Web of Science, named Dr. Ballantyne as a “Highly Cited…

View full profile